Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Observations Regarding the 24-Month Results of the LIGHTSITE III Trial.

Retina (Philadelphia, Pa.)·2026

Same author

Intravitreal Methotrexate for Complex Retinal Detachment.

Ophthalmic surgery, lasers & imaging retina·2026

Same author

Characterizing the Treatment Courses of Ranibizumab and Panretinal Photocoagulation for Retinopathy of Prematurity.

Journal of pediatric ophthalmology and strabismus·2026

Same author

Echogenic Diagnosis of Bilateral Subretinal Abscesses in a Patient with Group B Streptococcus Endogenous Endophthalmitis.

Retinal cases & brief reports·2026

Same author

Clinical Report of Epidemiological Trends in Child Abuse-Related Ocular Injuries (Ages 0 to 3 Years).

Journal of pediatric ophthalmology and strabismus·2025

Same author

Retinal and choroidal changes following corneal collagen cross-linking in keratoconus: a systematic review and meta-analysis of OCT and OCTA studies.

International journal of retina and vitreous·2025

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

Nanotechnology in ophthalmology.

Marco A Zarbin¹, Carlo Montemagno, James F Leary

¹Institute of Ophthalmology and Visual Science, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, NJ 07103, USA. zarbin@umdnj.edu

Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie

|September 28, 2010

Summary

This summary is machine-generated.

Nanotechnology and nanomedicine offer revolutionary approaches to ophthalmic diseases by enabling molecular-level interventions. This field promises to address current challenges and develop new therapies for previously untreatable conditions.

More Related Videos

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Microfabrication of Implantable Optics Integrated in a Microstructured Imaging Window for Advanced In Vivo Imaging

Microfabrication of Implantable Optics Integrated in a Microstructured Imaging Window for Advanced In Vivo Imaging

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy

Published on: September 27, 2021

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

Microfabrication of Implantable Optics Integrated in a Microstructured Imaging Window for Advanced In Vivo Imaging

Microfabrication of Implantable Optics Integrated in a Microstructured Imaging Window for Advanced In Vivo Imaging

Published on: April 11, 2025

Area of Science:

Nanotechnology and Nanomedicine
Ophthalmology
Biomedical Engineering

Background:

Nanotechnology involves engineering materials and devices at the nanoscale (<100 nm) for precise molecular-level interactions.
Nanomedicine aims to monitor, control, repair, and improve biological systems at the molecular level using nanodevices.
Current therapeutic challenges in ophthalmology include drug delivery and postoperative scarring, with some conditions remaining untreatable.

Purpose of the Study:

To review the general principles of nanotechnology applied to nanomedicine.
To explore current and potential applications of nanotechnology in ophthalmology.
To discuss the revolutionary potential and remaining obstacles of nanomedicine in treating eye diseases.

Main Methods:

Review of general nanotechnology principles relevant to nanomedicine, including biomimicry and pseudointelligence.
Examination of specific nanotechnology applications in ophthalmology.
Discussion of therapeutic challenges and potential solutions offered by nanomedicine.

Main Results:

Nanotechnology applications in ophthalmology include treatments for oxidative stress, intraocular pressure measurement, and theranostics.
Nanoparticles show promise for treating choroidal neovascularization, preventing glaucoma surgery scarring, and delivering gene therapy for retinal diseases.
Regenerative nanomedicine and nanoprosthetics are emerging areas with significant potential.

Conclusions:

Nanotechnology is poised to revolutionize ophthalmic therapeutics, addressing current limitations and enabling sight-restoring treatments for degenerative diseases.
Despite challenges in safe manufacturing and potential biological consequences, nanomedicine offers groundbreaking solutions for ophthalmic conditions.
The field of nanomedicine holds immense promise for the future of eye care and treating previously intractable diseases.